Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioShield House Compromise Could Serve As Template For Senate

Executive Summary

The House Energy & Commerce Committee and White House funding compromise for Project BioShield could serve as a template for agreement in the Senate

You may also be interested in...



FDA Biologics Center Performance To Be Reviewed By Advisory Committees

The Center for Biologics Evaluation & Research will use its advisory committees to perform an external review of its operations

FDA Biologics Center Performance To Be Reviewed By Advisory Committees

The Center for Biologics Evaluation & Research will use its advisory committees to perform an external review of its operations

“BioShield” Law Nears Passage; FDA Proposes “Pre-Pre-IND” Meetings

FDA counterterrorism regulations will likely face added scrutiny following the expected enactment of Project BioShield, which allows for wider use of investigational products in emergency situations

Related Content

UsernamePublicRestriction

Register

PS041801

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel